BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Diagnosis
38 results:

  • 1. Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma.
    Parol-Kulczyk M; Durślewicz J; Blonkowska L; Wujec R; Gzil A; Piątkowska D; Ligmanowska J; Grzanka D
    J Pathol Clin Res; 2024 Mar; 10(2):e12365. PubMed ID: 38436543
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Lysine methyltransferase 5C increases the proliferation and metastatic abilities of clear cell renal cell carcinoma via aerobic glycolysis.
    Zeng B; Wan R; Chang K; Li J; Zhang X; Shi G; Ye D; Xu F
    Int J Oncol; 2024 Apr; 64(4):. PubMed ID: 38426605
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Deep learning algorithm (YOLOv7) for automated renal mass detection on contrast-enhanced MRI: a 2D and 2.5D evaluation of results.
    Anari PY; Lay N; Zahergivar A; Firouzabadi FD; Chaurasia A; Golagha M; Singh S; Homayounieh F; Obiezu F; Harmon S; Turkbey E; Merino M; Jones EC; Ball MW; Linehan WM; Turkbey B; Malayeri AA
    Abdom Radiol (NY); 2024 Apr; 49(4):1194-1201. PubMed ID: 38368481
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions.
    Mei S; Alchahin AM; Tsea I; Kfoury Y; Hirz T; Jeffries NE; Zhao T; Xu Y; Zhang H; Sarkar H; Wu S; Subtelny AO; Johnsen JI; Zhang Y; Salari K; Wu CL; Randolph MA; Scadden DT; Dahl DM; Shin J; Kharchenko PV; Saylor PJ; Sykes DB; Baryawno N
    Genome Med; 2024 Jan; 16(1):1. PubMed ID: 38281962
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of key genes and validation of key gene aquaporin 1 on Wilms' tumor metastasis.
    Liu H; Jin C; Yang X; Xia N; Guo C; Dong Q
    PeerJ; 2023; 11():e16025. PubMed ID: 37904849
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Brusatol enhances MEF2A expression to inhibit RCC progression through the Wnt signalling pathway in renal cell carcinoma.
    Wang T; Zhou Y; Bao H; Liu B; Wang M; Wang L; Pan T
    J Cell Mol Med; 2023 Dec; 27(23):3897-3910. PubMed ID: 37859585
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Application of CT Radiomics in the diagnosis of Vein Wall Invasion in Patients With Renal Cell Carcinoma Combined With Tumor Thrombus.
    Zhao X; Yan Y; Xie W; Zhao L; Zhang S; Liu J; Liu C; Ma L
    Oncologist; 2024 Feb; 29(2):151-158. PubMed ID: 37672362
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. EMX2OS targeting IGF2BP1 represses Wilms' tumour stemness,epithelial-mesenchymal transition and metastasis.
    Zhang HM; Cui MY; Chen ZH
    J Genet; 2023; 102():. PubMed ID: 36722215
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Systematic Pan-Cancer Analysis and Experimental Verification Identify FOXA1 as an Immunological and Prognostic Biomarker in Epithelial Ovarian Cancer.
    Wang K; Guan C; Yu J; Chen X; Shang X; Mei S; Feng X; Zheng L
    Dis Markers; 2022; 2022():9328972. PubMed ID: 36393971
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A diagnostic miRNA panel to detect recurrence of ovarian cancer through artificial intelligence approaches.
    Aghayousefi R; Hosseiniyan Khatibi SM; Zununi Vahed S; Bastami M; Pirmoradi S; Teshnehlab M
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):325-341. PubMed ID: 36378340
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. KLK4 Silencing Inhibits the Growth of Chromophobe Renal Cell Carcinoma through ERK/AKT Signaling Pathway.
    Fan B; Niu Y; Zhang A; Wei S; Ma Y; Su J; Ren Z
    Kidney Blood Press Res; 2022; 47(12):702-710. PubMed ID: 36260980
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The inhibitory effect of betulinic acid on epithelial-mesenchymal transition pathway in renal cell carcinoma.
    Ataş MN; Ertuğrul B; İplik ES; Çakmakoğlu B; Ergen A
    Med Oncol; 2022 Aug; 39(11):170. PubMed ID: 35972672
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. PKMYT1, exacerbating the progression of clear cell renal cell carcinoma, is implied as a biomarker for the diagnosis and prognosis.
    Chen J; Hua X; Chen H; Qiu X; Xiao H; Ge S; Liang C; Zhou Q
    Aging (Albany NY); 2021 Dec; 13(24):25778-25798. PubMed ID: 34959223
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identification of candidate biomarker
    Lv Q; Xiao W; Xiong Z; Shi J; Miao D; Meng X; Yuan H; Yang H; Zhang X
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1176-1190. PubMed ID: 34856762
    [No Abstract]    [Full Text] [Related]  

  • 15. YBX1 knockdown induces renal cell carcinoma cell apoptosis via Kindlin-2.
    Cui Q; Wang C; Liu S; Du R; Tian S; Chen R; Geng H; Subramanian S; Niu Y; Wang Y; Yue D
    Cell Cycle; 2021 Nov; 20(22):2413-2427. PubMed ID: 34709966
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Tuftelin 1 (TUFT1) Promotes the Proliferation and Migration of Renal Cell Carcinoma
    Lin H; Zeng W; Lei Y; Chen D; Nie Z
    Pathol Oncol Res; 2021; 27():640936. PubMed ID: 34257606
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Recent Advances in Pathology: the 2021 Annual Review Issue of The Journal of Pathology.
    Herrington CS; Poulsom R; Koeppen H; Coates PJ
    J Pathol; 2021 Jul; 254(4):303-306. PubMed ID: 34097314
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Circ_RPL23A acts as a miR-1233 sponge to suppress the progression of clear cell renal cell carcinoma by promoting ACAT2.
    Cheng L; Cao H; Xu J; Xu M; He W; Zhang W; Dong L; Chen D
    J Bioenerg Biomembr; 2021 Aug; 53(4):415-428. PubMed ID: 34036483
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma.
    Zhang Y; Chen M; Liu M; Xu Y; Wu G
    Oxid Med Cell Longev; 2021; 2021():6699808. PubMed ID: 33564363
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Circular RNA circ_001842 plays an oncogenic role in renal cell carcinoma by disrupting microRNA-502-5p-mediated inhibition of SLC39A14.
    Zeng J; Feng Q; Wang Y; Xie G; Li Y; Yang Y; Feng J
    J Cell Mol Med; 2020 Sep; 24(17):9712-9725. PubMed ID: 32729666
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.